Skip to Main Content

Paper Details

Phase Ib Study of Glasdegib, a Hedgehog Pathway Inhibitor, in Combination with Standard Chemotherapy in Patients with AML or High-Risk MDS.
Clin Cancer Res
81
2018
Author NameAffiliation
Daniel A PollyeaUniversity of Colorado School of Medicine
Vivian G OehlerFred Hutchinson Cancer Research Center
Hagop KantarjianUniversity of Texas, MD Anderson Cancer Center
Jorge CortesUniversity of Texas, MD Anderson Cancer Center
  • 1 - 4

Datasets

Release 1.2